Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Consun Pharmaceutical Group Ltd. ( (HK:1681) ) is now available.
Consun Pharmaceutical Group Limited, a company incorporated in the Cayman Islands, has announced proposed amendments to its existing memorandum and articles of association. These amendments aim to allow the company to hold and dispose of repurchased shares as treasury shares, in line with Cayman Islands law and recent changes to the Hong Kong Stock Exchange’s listing rules. The changes are pending shareholder approval at an upcoming extraordinary general meeting.
The most recent analyst rating on (HK:1681) stock is a Buy with a HK$17.00 price target. To see the full list of analyst forecasts on Consun Pharmaceutical Group Ltd. stock, see the HK:1681 Stock Forecast page.
More about Consun Pharmaceutical Group Ltd.
Average Trading Volume: 3,449,066
Technical Sentiment Signal: Buy
Current Market Cap: HK$12.33B
For an in-depth examination of 1681 stock, go to TipRanks’ Overview page.